May 3, 2016
IMS Health Holdings, Inc. (NYSE:IMS) and Quintiles Transnational Holdings Inc. (NYSE:Q) announced today that their respective boards of directors approved a definitive merger agreement, pursuant to […]
May 2, 2016
Epigenomics AG: China FDA names Epigenomics’ blood-based Septin9 colorectal cancer test a most innovative medical product for 2015 Berlin (Germany) and Germantown, MD (U.S.A.), May 2, […]
April 14, 2016
From LABIOTECH.EU http://labiotech.eu/epigenomics-epiprocolon-interview-blood-test-cancer-colon-diagnostics-us/ We met the Biotech that just launched the First & Only Blood Test for Colorectal Cancer in the US 14/04/2016 Colorectal cancer is […]
April 13, 2016
Apr. 13, 2016 2:19 PM ET In pulling off the almost unheard-of feat of successfully appealing against an FDA rejection, Epigenomics (OTCQX:EPGNF) today got full approval […]
April 13, 2016
-First and only blood-based colorectal cancer screening test approved by the FDA -Innovative, convenient and effective screening option for millions of eligible Americans -Commercialization initiated with […]
April 13, 2016
12-April-2016 Curetis AG / Curetis Publishes Full-Year 2015 Financial Results and Introduces 2016 Guidance . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is […]
April 13, 2016
http://www.japantimes.co.jp/news/2016/04/12/national/science-health/massive-whole-genome-study-finds-six-types-of-liver-cancer/#.Vw5qsJMrIUE
April 7, 2016
BioChain Acquires China Rights To Epigenomics AG Lung Cancer IVD [4/6/2016] BioChain, a US-China diagnostics/genomics tools company, has in-licensed China rights to a novel blood-based lung […]
April 5, 2016
View press release here: http://www.prnewswire.com/news-releases/cryoport-chosen-to-provide-cold-chain-logistics-support-to-proteogenex-300245387.html
